Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma

Viragova, S., Aparicio, L., Palmerini, P., Zhao, J., Valencia Salazar, L. E., Schurer, A., Dhuri, A., Sahoo, D., Moskaluk, C. A., Rabadan, R., & Dalerba, P. (2023). Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma. JNCI: Journal of the National Cancer Institute, 115(7), 838–852. https://doi.org/10.1093/jnci/djad062
Authors:
Sara Viragova
Luis Aparicio
Pierangela Palmerini
Junfei Zhao
Luis E Valencia Salazar
Alexandra Schurer
Anika Dhuri
Debashis Sahoo
Christopher A Moskaluk
Raul Rabadan
Piero Dalerba
Affiliated Authors:
Sara Viragova
Luis Aparicio
Pierangela Palmerini
Junfei Zhao
Luis E Valencia Salazar
Alexandra Schurer
Anika Dhuri
Raul Rabadan
Piero Dalerba
Columbia Affiliation:
Subjects:
Antineoplastic Agents (MeSH)
Carcinoma, Adenoid Cystic (MeSH)
Receptors, Retinoic Acid (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1093/jnci/djad062
PMID:
37040084
DOI:
10.1093/jnci/djad062
Journal:
Journal of the National Cancer Institute
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: